INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2023 results. “We are pleased to have delivered another year of strong performance in 2023, enabled by our relentless focus on customer experience and affordability, and continued investments in growth and innovation. The balance and resilience of our business coupled with the focused execution of our enterprise strategy supports our confidence in our outlook for 2024, as we continue to optimize the found ...

Wall Street analysts forecast that Elevance Health (ELV) will report quarterly earnings of $5.55 per share in its upcoming release, pointing to a year-over-year increase of 6.1%. It is anticipated that revenues will amount to $41.82 billion, exhibiting an increase of 5.4% compared to the year-ago quarter.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course o ...

Elevance Health, Inc. (ELV) is set to report its fourth-quarter 2023 results on Jan 24, before the opening bell. This time around, the company’s overall earnings performance is likely to have received a boost from higher segmental profits, only to be undone by reduced total medical memberships and higher costs.What Do the Estimates Say?The Zacks Consensus Estimate for fourth-quarter earnings per share of $5.55 suggests a 6.1% increase from the prior-year figure of $5.23. The consensus mark remained stable o ...

Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and HealthEquity (HQY) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate re ...

Elevance Health - Elevance Health是医疗行业的一员，拥有Zacks Sector Rank排名第5[2] - Elevance Health目前的Zacks Rank为2（买入），显示其盈利前景较为乐观[3] - Elevance Health今年以来的回报率为0.4%，表现优于医疗行业平均回报率-0.7%[5] - Elevance Health属于医疗服务行业，今年以来的回报率优于该行业平均回报率-6.3%[8] Axonics Modulation Technologies - Axonics Modulation Technologies是另一家医疗股票，今年以来表现优于行业，回报率为9.8%[6] - Axonics Modulation Technologies当前的Zacks Rank为1（强烈买入），盈利预期增长186.5%[7] - Axonics Modulation Technologies属于医疗信息系统行业，该行业今年以来回报率增长18.2%[9] - 投资者应继续关注Elevance Health和Axonics Modulation Technologies，因为它们可能会保持良好的表现[10]

Elevance Health, Inc. (ELV) is positioned for growth with premium rate adjustments in the Health Benefits business, an expanding external pharmacy membership base and overall strength in the Carelon business. The BioPlus acquisition is expected to continue supporting the Carelon unit’s performance.Elevance — with a market cap of $111.6 billion — is one of the largest publicly traded health benefits companies in the United States. Courtesy of solid prospects, this currently Zacks Rank #3 (Hold) stock is wort ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium includes access to the Zacks Style Scores as well.What are the Zacks Style Scores?T ...

The most recent trading session ended with Elevance Health (ELV) standing at $475.12, reflecting a -1.49% shift from the previouse trading day's closing. This move lagged the S&P 500's daily gain of 0.08%. Elsewhere, the Dow saw a downswing of 0.31%, while the tech-heavy Nasdaq appreciated by 0.02%.The the stock of health insurer has risen by 0.51% in the past month, lagging the Medical sector's gain of 6.57% and the S&P 500's gain of 3.52%.Analysts and investors alike will be keeping a close eye on the per ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium includes access to the Zacks Style Scores as we ...

ELV的合作与服务 - ELV宣布将为符合条件的Medicaid健康计划参与者提供高质量智能手机，包括无限短信、通话和数据服务，增强ELV的服务[1] - ELV与Verizon、AT&T、T-Mobile和Samsung合作，通过Affordable Connectivity Program获得资金，为会员提供高质量服务，帮助弥合拥有智能手机和没有智能手机的人之间的鸿沟[2] ELV的新计划 - ELV的新计划将在2024年在多个州推出，旨在扩大覆盖范围，帮助减少医疗不平等，服务更多人群[3]